These limits from the BTNX NTS are remarkably appropriate, as we located e.g. etodesnitazene to have the same in vitro potency and efficacy as fentanyl [seven, 13] and as it could potentially give PWUD a Untrue sense of safety. Moreover, the detectability of nitazene analogues in drug samples may be impacted by solubility issues, as highlighted by